Product
Standard of Care PD-1 Therapy
1 clinical trial
13 indications
Indication
MelanomaIndication
Breast CancerIndication
Merkel Cell CarcinomaIndication
Squamous Cell CarcinomaIndication
Lung CancerIndication
Cervical CancerIndication
Bladder CancerIndication
Ovarian CancerIndication
Hepatocellular CarcinomaIndication
Small Cell Lung CancerIndication
Microsatellite Instability HighIndication
Stomach CancerIndication
Esophageal cancerClinical trial
Pilot Evaluation of Focused Ultrasound Ablation and Focused Ultrasound Ablation Plus PD-1 Antibody Blockade in Advanced Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2024-02-01